Drew J Fromkin Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Drew J Fromkin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Drew J Fromkin. Drew J Fromkin is EVP and Chief Marketing Off. in CLINICAL DATA INC ($NOVI) and Director in Tobira Therapeutics, Inc. ($TBRA) and Director in Health Sciences Acquisitions Corp ($HSAC).
Latest Insider Trading Transactions of Drew J Fromkin
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, NOVI, IMVT, TBRA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2021 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Director | Option Exercise | A | 17.00 | 23,300 | 396,100 | 23,300 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Director | Grant | A | 0.00 | 15,500 | 0 | 40,200 | 24.7 K to 40.2 K (+62.75 %) |
| May 18 2020 | HSAC | Immunovant, Inc. | Fromkin Andrew J. | Director | Option Exercise | A | 19.01 | 37,000 | 703,370 | 37,000 | |
| May 18 2020 | HSAC | Immunovant, Inc. | Fromkin Andrew J. | Director | Grant | A | 0.00 | 24,700 | 0 | 24,700 | 0 to 24.7 K |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Fromkin Andrew J. | Director | Option Exercise | A | 8.43 | 77,181 | 650,636 | 77,181 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Fromkin Andrew J. | Director | Option Exercise | A | 8.43 | 77,181 | 650,636 | 77,181 | |
| Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Option Exercise | D | 8.19 | 17,695 | 144,922 | 0 | |
| Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Option Exercise | D | 7.91 | 17,778 | 140,624 | 0 | |
| Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Option Exercise | D | 16.52 | 15,500 | 256,060 | 0 | |
| Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Option Exercise | D | 58.23 | 5,666 | 329,931 | 0 | |
| Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Sell | U | 0.00 | 5 | 0 | 0 | 5 to 0 (-100.00 %) |
| Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Sell | U | 0.00 | 11 | 0 | 0 | 11 to 0 (-100.00 %) |
| Jan 14 2016 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Option Exercise | A | 7.91 | 17,778 | 140,624 | 17,778 | |
| Jul 13 2015 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Option Exercise | A | 16.52 | 15,500 | 256,060 | 15,500 | |
| Oct 19 2005 | NOVI | CLINICAL DATA INC | Fromkin Drew J | EVP and Chief Marke ... | Option Exercise | A | 17.89 | 50,000 | 894,500 | 50,000 |
Page: 1